The cGMP Buffers & Liquids solutions are manufactured in its state-of-the-art facility at Valladolid (Spain) that meets the highest standards of quality and regulatory compliance: ISO 9001:2015, ISO 13485:2016 for the Research use Raw Materials and Ancillary Reagents, cGMP, current Good Manufacturing Practice according to ICH Q7 and in continuous improvement.

Canvax´s team has a wide experience across all stages of the biopharmaceutical value chain, from research up to clinical stage: “It enables our partners to a no-risk transition from pilot to full-scale production batches quickly, without the disruptive fluctuations in quality and unbeatable batch to batch consistency”, Jesús C. Morales, Business Development Manager of the company said. Its portfolio includes the most used buffers, liquid solutions, custom blends, chemicals and dilutions suitable to be used as raw materials for Vaccines, Cell or Protein based Therapies, Diagnostics, Veterinary and much more applications.

“Products are manufactured to ensure the best solution in terms of performance, traceability, batch to batch consistency and compliance with the highest standards in terms of efficacy and safety required in each country”, Morales added. Additionally, Canvax can customize the formula or manufacturing grade, starting from Research grade to Clinical grade according to GMP on a commercial scale. It enables its worldwide customers to go from lab-scale to commercial-scale in a few weeks. "We believe this will help our customers shorten the path from an idea to a commercial scale manufacturing”, Morales added.